Pfenex's Series A Round

Pfenex raised a round of funding on December 18, 2009.

Pfenex is a clinical-stage biotechnology company that is developing complex therapeutic proteins. Using the patented Pfenex Expression Technology platform, the company has created an advanced pipeline…

Articles about Pfenex's Series A Round: